|
An ancient protein balances gene activity and silences foreign DNA in bacteria
May 16, 2008Compared to humans, bacteria have a much tidier genome. The tiny microorganisms pack their genes closely together, and don't carry around a lot of extraneous DNA, so-called junk DNA that fills in the gaps between genes. Some 90 percent of the complete genome sequence of the bacteria E. coli contains sequences of DNA that code for protein, while 90 percent of the human genome is non-coding junk DNA.
Now it appears that the tidiness of these bacterial genomes may be attributed to an ancient protein. A new study led by researchers at NYU Langone Medical Center reveals that this protein, called Rho, serves a regulatory function, maintaining boundaries between genes in E. coli and ensuring that the bacterium produces proteins needed for immediate cellular functions. The study also found that Rho and its co-factors silence so-called foreign DNA in the bacterium, which had been acquired by swapping genes with other bacteria. E. coli is a common denizen of the human gut. While most strains are harmless, some can cause serious illness.
The study is published in May 16, 2008 issue of the journal Science.
Rho was one of the first termination factors discovered in bacteria. These factors act as red lights to gene transcription. However it wasn't clear until now how many genes were affected by Rho and why it was so essential to bacterial survival. If you knock out Rho, bacterial cells die. The new study explains this mystery.
"Our study shows that Rho is really pervasive and it terminates transcription in nearly every gene," says Evgeny Nudler, Ph.D., a Professor of Biochemistry at NYU Langone Medical Center, one of the study's authors. "The first major role of Rho is to adjust the levels of transcription to the translational needs of the bacteria." In other words, Rho makes sure the bacterium isn't burdened with too much protein. "Rho is needed for survival because it appears to keep potentially toxic genes at bay," says Dr. Nudler. Transcription is the first step toward making a working protein and translation is the second step.
"Rho is an ancient protein and it is found throughout bacteria," says Christopher J. Cardinale, an M.D.-Ph.D. student in Dr. Nudler's laboratory and the first author on the paper. He speculates that Rho's pervasive function as a genetic boundary keeper enables bacteria to grow quickly. "Bacteria are so small and they don't carry around a lot of extra DNA. Throughout evolution Rho may have allowed genes to be packed close together, so that in turn enabled bacteria to grow quickly."
The elegant study combined the power of genomics, which allowed the researchers to assay the activity of the entire genomes of four strains of E. coli, and of proteomics, the genome-wide analysis of proteins. The NYU Langone Medical Center researchers and their colleagues at Columbia University Medical Center and Rutgers figured out what role Rho plays in the cell by evaluating the response of E. coli to the widely used animal antibiotic bicyclomycin, which specifically inhibits Rho. They could see which genes were switched on and off when Rho wasn't functioning. In the second part of the study, they used a powerful robotic technique called DIGE (differential gene electrophoresis) to pluck out proteins produced by genes in E. coli in response to the antibiotic, and then employed mass spectrometry to identify these proteins.
The protein analysis showed that Rho, along with two co-factors, was silencing foreign DNA in E. coli. This foreign DNA, inserted into E. coli millions of years ago, was toxic to the cell. "It was really surprising that the genes that were the most actively regulated by Rho were those genes acquired by horizontal events [gene swapping], and not the genes belonging to the bacteria," said Dr. Nudler.
Drs. Nudler and Cardinale said that there were no immediate clinical applications of their findings, but they speculated that their findings may be of use in the development of other antibiotics that target Rho. Most bacterial resistance to antibiotics is acquired through horizontal transfer, they point out.
NYU Langone Medical Center / New York University School of Medicine
Rho was one of the first termination factors discovered in bacteria. These factors act as red lights to gene transcription. However it wasn't clear until now how many genes were affected by Rho and why it was so essential to bacterial survival. If you knock out Rho, bacterial cells die. The new study explains this mystery.
"Our study shows that Rho is really pervasive and it terminates transcription in nearly every gene," says Evgeny Nudler, Ph.D., a Professor of Biochemistry at NYU Langone Medical Center, one of the study's authors. "The first major role of Rho is to adjust the levels of transcription to the translational needs of the bacteria." In other words, Rho makes sure the bacterium isn't burdened with too much protein. "Rho is needed for survival because it appears to keep potentially toxic genes at bay," says Dr. Nudler. Transcription is the first step toward making a working protein and translation is the second step.
"Rho is an ancient protein and it is found throughout bacteria," says Christopher J. Cardinale, an M.D.-Ph.D. student in Dr. Nudler's laboratory and the first author on the paper. He speculates that Rho's pervasive function as a genetic boundary keeper enables bacteria to grow quickly. "Bacteria are so small and they don't carry around a lot of extra DNA. Throughout evolution Rho may have allowed genes to be packed close together, so that in turn enabled bacteria to grow quickly."
The elegant study combined the power of genomics, which allowed the researchers to assay the activity of the entire genomes of four strains of E. coli, and of proteomics, the genome-wide analysis of proteins. The NYU Langone Medical Center researchers and their colleagues at Columbia University Medical Center and Rutgers figured out what role Rho plays in the cell by evaluating the response of E. coli to the widely used animal antibiotic bicyclomycin, which specifically inhibits Rho. They could see which genes were switched on and off when Rho wasn't functioning. In the second part of the study, they used a powerful robotic technique called DIGE (differential gene electrophoresis) to pluck out proteins produced by genes in E. coli in response to the antibiotic, and then employed mass spectrometry to identify these proteins.
The protein analysis showed that Rho, along with two co-factors, was silencing foreign DNA in E. coli. This foreign DNA, inserted into E. coli millions of years ago, was toxic to the cell. "It was really surprising that the genes that were the most actively regulated by Rho were those genes acquired by horizontal events [gene swapping], and not the genes belonging to the bacteria," said Dr. Nudler.
Drs. Nudler and Cardinale said that there were no immediate clinical applications of their findings, but they speculated that their findings may be of use in the development of other antibiotics that target Rho. Most bacterial resistance to antibiotics is acquired through horizontal transfer, they point out.
NYU Langone Medical Center / New York University School of Medicine
Gene Activity News and Current Gene Activity Events RSSIdentification of protein able to stimulate production of T-cells
A team of Canadian and Finnish scientists has identified a protein able to stimulate the production of T-cells, the white blood cells involved in the recognition and the elimination of infectious agents.
'Smothered' genes combine with mutations to yield poor outcome in cancer patients
Johns Hopkins Kimmel Cancer Center researchers have identified a set of genes in breast and colon cancers with a deadly combination of traditional mutations and "smothered" gene activity that may result in poor outcomes for patients.
Dartmouth researchers discover gene signatures for scleroderma
Distinct genetic profiles can discern different groups of patients with scleroderma, a vexing autoimmune disease in which the body turns against itself, Dartmouth Medical School researchers report.
Deep sequencing study reveals new insights into human transcriptome
In a collaborative project scientists from the Max-Planck-Institute for Molecular Genetics in Berlin (MPI MolGen), Germany and Genomatix with a business in Munich, Germany and Ann Arbor, MI, USA, applied next generation sequencing and analysis methods to generate an unprecedented view at the human transcriptome.
Cancer-killing viruses influence tumor blood-vessel growth
Viruses genetically designed to kill cancer cells offer a promising strategy for treating incurable brain tumors such as glioblastoma, but the body's natural defenses often eliminate the viruses before they can eliminate the tumor.
Oocyte-specific gene mutations cause premature ovarian failure
Mutations in a gene called FIGLA cause premature ovarian failure in at least a percentage of women who suffer from the disorder, said researchers from Baylor College of Medicine in Houston and Shandong University in China in a report that appears online today in the American Journal of Human Genetics.
Many paths, few destinations: How stem cells decide what they'll be
How does a stem cell decide what specialized identity to adopt - or simply to remain a stem cell? A new study suggests that the conventional view, which assumes that cells are "instructed" to progress along prescribed signaling pathways, is too simplistic.
Scientists discover small RNAs that regulate gene expression and protect the genome
RNA is best known as a working copy of the DNA sequence of genes. In this role, it's a carrier of the genes' instructions to the cell, which manufactures proteins according to information in the RNA molecule.
Genetic 'tag team' keeps cells on cycle
By surveying the activity of thousands of genes at several different time points, researchers at the Duke Institute for Genome Sciences & Policy have uncovered new evidence that a network of influential genes act as a kind of genetic tag team to orchestrate one of the most fundamental aspects of all life: the cell cycle.
'Destruct' triggers may be jammed in tumor cells, UF geneticists say
Tumor cells living in the cross hairs of radiation or chemotherapy may be able to escape death because their self-destruct mechanisms are jammed, say University of Florida scientists writing in a recent issue of Developmental Cell.
More Gene Activity News Articles
 | The Measure of a Man by Gene A. Getz |
 | The Measure Of A Woman by Gene A. Getz, Elaine A. Getz |
 | The Expressive Arts Activity Book: A Resource for Professionals by Suzanne Darley, Wende Heath |
| Biblical Theology of Material Possessions by Gene A. Getz | |
 | Best Back-To-School Jokes by Gene Perret |
| Reflections of Shaver Lake: Center of activities on Pine Ridge for more than one hundred years by Gene Rose | |
 | Official Guidebook (Duel Masters) |
| Gene Activity in Early Development by Eric H. Davidson | |
| Real Prosperity: Biblical Principles of Material Possessions by Gene Getz | |
| World history and art: Overhead transparencies, teaching strategies, activity sheets by Gene A Mittler |
| © 2008 BrightSurf.com |